These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3707598)

  • 1. Inhibition of liver glutathione S-transferase activity in rats by hypolipidemic drugs related or unrelated to clofibrate.
    Foliot A; Touchard D; Mallet L
    Biochem Pharmacol; 1986 May; 35(10):1685-90. PubMed ID: 3707598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of hepatic glutathione S-transferase activity as a cause of reduced biliary sulfobromophthalein excretion in clofibrate-treated rats.
    Foliot A; Touchard D; Celier C
    Biochem Pharmacol; 1984 Sep; 33(18):2829-34. PubMed ID: 6477642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible inhibition of hepatic glutathione S-transferase by ciprofibrate, a peroxisome proliferator.
    Awasthi YC; Singh SV; Goel SK; Reddy JK
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1012-8. PubMed ID: 6487318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of sulfobromophthalein biliary excretion and inhibition of glutathione S-transferase activity induced by perhexiline maleate in rats.
    Mariscal MA; Muñoz ME; Collado PS; Esteller A; Gonzalez J
    Biochem Pharmacol; 1988 Sep; 37(18):3461-5. PubMed ID: 3421996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hepatocellular transport of sulfobromophthalein-glutathione by clofibrate treated, perfused rat liver.
    Sorrentino D; Weisiger RA; Bass NM; Licko V
    Lipids; 1989 May; 24(5):438-42. PubMed ID: 2755320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mitochondrial respiration and oxygen-dependent hepatotoxicity by six structurally dissimilar peroxisomal proliferating agents.
    Keller BJ; Yamanaka H; Thurman RG
    Toxicology; 1992; 71(1-2):49-61. PubMed ID: 1729767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of clofibric and beclobric acid in rat and monkey hepatocyte primary culture: influence on peroxisomal and mitochondrial beta-oxidation and the activity of catalase, glutathione S-transferase and glutathione peroxidase.
    Mennes WC; Wortelboer HM; Hassing GA; van Sandwijk K; Timmerman A; Schmid BP; Jahn U; Blaauboer BJ
    Arch Toxicol; 1994; 68(8):506-11. PubMed ID: 7802591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of peroxisome proliferators on glutathione-dependent sulphobromophthalein excretion.
    James SI; Ahokas JT
    Xenobiotica; 1992 Dec; 22(12):1425-32. PubMed ID: 1494887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species differences in the hepatic response to a potent peroxisome proliferator.
    Makowska JM; Bonner FW; Goldfarb PS; Gibson GG
    Biochem Soc Trans; 1989 Dec; 17(6):1072-3. PubMed ID: 2628085
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation.
    Makowska JM; Anders C; Goldfarb PS; Bonner F; Gibson GG
    Biochem Pharmacol; 1990 Sep; 40(5):1083-93. PubMed ID: 2390105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of three hypolipidemic drugs on catalase activity and peroxisomal and mitochondrial palmitate oxidation in rat cardiac and skeletal muscle.
    MacDonald RS; Swan PB
    Biochim Biophys Acta; 1986 Feb; 880(2-3):153-60. PubMed ID: 3942787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of joint exposures to selected peroxisome proliferators on hepatic acyl-CoA oxidase activity in male B6C3F1 mice.
    Ochs JB; Baldwin LA; Leonard DA; Calabrese EJ
    Hum Exp Toxicol; 1992 Mar; 11(2):83-8. PubMed ID: 1349224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymes.
    Thomas H; Schladt L; Knehr M; Post K; Oesch F; Boiteux-Antoine AF; Fournel-Gigleux S; Magdalou J; Siest G
    Biochem Pharmacol; 1989 Jun; 38(12):1963-9. PubMed ID: 2500933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity in the action of hypolipidemic drugs: increase of peroxisomal beta-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat.
    Lazarow PB; Shio H; Leroy-Houyet MA
    J Lipid Res; 1982 Feb; 23(2):317-26. PubMed ID: 7077146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of liver peroxisomal proteins as compared to other organelle marker enzymes in rats treated with hypolipidemic agents.
    Cherkaoui Malki M; Bardot O; Lhuguenot JC; Latruffe N
    Biol Cell; 1990; 69(2):83-92. PubMed ID: 2271901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro.
    Gupta RC; Goel SK; Earley K; Singh B; Reddy JK
    Carcinogenesis; 1985 Jun; 6(6):933-6. PubMed ID: 4006083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential proto-oncogene mRNA induction from rats treated with peroxisome proliferators.
    Cherkaoui Malki M; Lone YC; Corral-Debrinski M; Latruffe N
    Biochem Biophys Res Commun; 1990 Dec; 173(3):855-61. PubMed ID: 2268348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of beclobric acid and clofibric acid on peroxisomal beta-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes.
    Blaauboer BJ; van Holsteijn CW; Bleumink R; Mennes WC; van Pelt FN; Yap SH; van Pelt JF; van Iersel AA; Timmerman A; Schmid BP
    Biochem Pharmacol; 1990 Aug; 40(3):521-8. PubMed ID: 2383284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of rat liver endoplasmic reticulum Ca(2+)-ATPase thiol integrity by ciprofibrate, a peroxisome proliferator.
    Bennett AM; Williams GM
    Biochem Pharmacol; 1993 May; 45(10):2093-8. PubMed ID: 8512590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of some hypolipidemic agents on biochemical values and hepatic peroxisomal enzymes in rats: comparison of probucol, CGA, KCD-232, MLM-160, AL-369 and clinofibrate with clofibrate.
    Watanabe T; Mitsukawa M; Horie S; Suga T; Seki K
    J Pharmacobiodyn; 1987 Mar; 10(3):142-7. PubMed ID: 3625448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.